FIELD: medicine, neurology, pharmacy.
SUBSTANCE: invention relates to an agent used in treatment of ischemic injuries in brain. Invention proposes an anxiolytic agent 5-ethoxy-2-[2-(morpholino)ethylthio]benzimidazole dihydrochloride (AFOBAZOL) that shows the expressed neuroprotective activity and can be recommended as an agent for treatment of ischemic insult and other ischemic brain injuries.
EFFECT: valuable medicinal properties of agent.
3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| MEDICINAL COMPOSITION | 2001 |
|
RU2213562C2 |
| METHOD OF TREATING ISCHEMIC STROKE | 2013 |
|
RU2554500C2 |
| COMBINED DRUG FOR PRIMARY NEUROPROTECTION | 2017 |
|
RU2636616C1 |
| MAGNESIUM BIS (2-AMINOETHANESULFONIC ACID)-BUTANEDIOATE, WHICH HAS ANTIHYPOXIC, NEUROPROTECTIVE AND HYPOCOAGULANT ACTIVITY | 2017 |
|
RU2671982C1 |
| MEDICINAL AGENT FOR PREVENTING AND TREATING CEREBRAL DISEASES AND METHOD OF TREATING CEREBRAL DISEASES | 2015 |
|
RU2692063C2 |
| METHOD OF TREATING CEREBRAL CIRCULATION DISTURBANCES | 2009 |
|
RU2401096C1 |
| INJECTION DOSAGE FORM FOR ACUTE STROKE TREATMENT, METHOD OF PRODUCTION AND APPLICATION THEREOF | 2005 |
|
RU2330680C2 |
| MEDICATION FOR TREATING CEREBRAL CIRCULATION DISORDERS AND BRAIN TRAUMAS | 2012 |
|
RU2554502C9 |
| AGENT FOR REDUCTION OF GLUTAMATE-INDUCED APOPTOSIS AND INHIBITION OF NMDA-RECEPTOR, POSSESSING IMMUNOMODULATORY ACTION, FOR TREATING NERVOUS SYSTEM DISORDERS, EFFECTS OF CRANIOCEREBERAL INJURY AND ISCHEMIC AND HEMORRHAGIC STROKE | 2013 |
|
RU2605339C2 |
| N-(5-HYDROXYNICOTINOYL)-L-GLUTAMIC ACID MONO- AND BIVALENT SALTS POSSESSING PSYCHOTROPIC (ANTIDEPRESSANT AND ANXIOLYTIC), NEUROPROTECTIVE, GEROPROTECTIVE AND ANTI-INSULT EFFECT | 2006 |
|
RU2314293C1 |
